Registration Options

Activity Date: 04/20/2021

AAPP 2021 registration is closed.

Session Time and Location

The live session is complete.

Session Summary

Access to buprenorphine continues to be problematic for many patients potentially due to stigma from patients, the healthcare system, and the community. During this session, we will explore what barriers others have encountered and how they have dealt with it. We will also explore the stigmas surrounding buprenorphine and brainstorm ideas for how to combat this problem. Though the recent HHS guidelines for enhanced buprenorphine access were not implemented, we will discuss how the culture of opioid prescribing and opioid use disorder treatment are changing.

Faculty Information and Disclosures

David Dadiomov, PharmD, BCPP
Mika Michaels, PharmD, BCPP

View biographical information and disclosures

Continuing Education Credit and Disclosures

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.